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Exercise-induced pulmonary hypertension (PHT) was 
defined historically as an increase of >30 mmHg in the mean 
pulmonary artery pressure (MPAP) during exercise in patients 
who otherwise had a normal MPAP at rest (1). This concept 
was adopted for almost two decades before it was dropped 
from the diagnostic criteria of PHT in 2008 following the 
4th World Symposium on PHT due to the ambiguity in the 
cut-off values for abnormality (2). In recent years, however, 
the tide might have turned. New and improved definitions 
for exercise PHT have been proposed and validated in a 
variety of patient cohorts, generating interest and bringing 
exercise PHT back into the limelight (3,4). As the latest 
iteration of the World Symposium on PHT in Nice 
approaches, this paper by van Riel et al. is both timely and 
relevant.
By way of introduction, exercise PHT is of potentially 
wide clinical use and carries important prognostic value. As 
a provocative test, it is capable of unmasking the underlying 
abnormal exercise pulmonary physiology in patients who 
have relatively normal resting pulmonary pressures (5). 
It has been shown to enable early detection of subclinical 
mild pulmonary arterial hypertension, which is a clinically 
relevant phase in the natural history of disease, lending 
opportunity for screening and perhaps early intervention 
before irreversible adverse pulmonary vascular remodelling 
sets in (5). Among patients with valvular heart diseases, 
the development of exercise PHT portents higher 
mortality, heart failure admission rates and post-operative 
cardiovascular events (6-10). As such, the importance of 
obtaining an accurate diagnosis of exercise-induced PHT 
cannot be over-emphasized. Right heart catheterisation 
remains the gold standard of pulmonary arterial pressures 
measurement and the cornerstone for the diagnosis of PHT 
despite its invasive nature.
In the study by van Riel et al., the authors compared 
the use of Doppler echocardiography to right-heart 
catheterisation at detecting PHT in a cohort of patients 
presenting with exertional intolerance but no prior history 
of PHT (11). The tricuspid regurgitation (TR) signals 
on Doppler echocardiogram were used for pulmonary 
artery pressure (PAP) calculations, which include systolic 
pulmonary artery pressure (SPAP) estimation from peak TR 
velocity and MPAP estimation from the TR velocity-time 
integral envelop. The TR signals were further graded from 
A to C, in the order of descending signal quality. Grade A 
TR signal was defined by extension of signal for at least half 
of ventricular systole and with a well-defined border, while 
grade B referred to signals with only one criterion fulfilled 
and grade C referred to signals with neither criterion 
fulfilled. In terms of feasibility, grade A signals were 
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detected in 68% of patients at rest and 34% during peak 
exercise. Although the percentage of grade A TR signals 
dropped by almost 1/3 from rest to exercise, the correlation 
of MPAP and SPAP between Doppler echocardiography 
and right heart catheterisation for grade A signals was not 
overtly affected. In fact, the correlation between these two 
modalities was slightly higher on exercise compared to its 
corresponding value at rest (r=0.72, bias −2.9±8.0 mmHg at 
rest and r=0.75, bias −1.9±15.6 mmHg on exercise). Patients 
with grades B and C TR signals had poor correlation with 
right heart catheterisation. In patients with grade A TR 
signals, the MPAP to workload ratio (MPAP/workload) 
at 1.4 mmHg/10 watts was able to predict an abnormal 
pulmonary hemodynamic response during exercise [defined 
as >3.0 mmHg/L/min increase in the MPAP/cardiac output 
(CO) slope] with a sensitivity of 91% and specificity of 
82% [area under the receiver operator’s curve 0.9, 95% 
confidence interval (CI), 0.77–1.0, P=0.001].
The correlations between exercise Doppler-derived PAP 
and that obtained from right heart catheterization in this 
paper were comparable to those reported in the literature 
(12,13) (Table 1). In the study by Kovacs et al., there 
was no significant difference in SPAP between exercise 
Doppler echocardiography and right heart catheterisation 
at increasing stages of semi-supine bicycle exercise (13). 
In a more recent study by Claessen et al., both MPAP and 
SPAP from echocardiography had good correlations with 
exercise cardiac magnetic resonance imaging combined 
with simultaneous invasive pressure registration (12). The 
echocardiographic-derived MPAP/CO was obtained in 
87% of the study subjects. It was able to identify patients 
with abnormal pulmonary vascular reserve, as defined by 
invasively-derived MPAP/CO of >3 mmHg/L/min.
van Riel et al. have also shown that MPAP/workload 
could be a viable surrogate for MPAP/CO assessment. 
There are, in fact, several theoretical advantages to this 
approach. For starter, workload and CO have been shown to 
demonstrate a linear relationship (14). Also, using workload 
in place of CO means no additional calculations for CO are 
required. This could circumvent the problem of inaccurate 
CO measurement, especially from echocardiography 
whereby geometrical assumption of left ventricular 
outflow tract (LVOT) shape is made and the position of 
LVOT pulse Doppler is difficult to assess during exercise. 
However, the clinical utility of MPAP/workload warrants 
further studies as there is considerable amount of individual 
variability in CO for the same workload (15). Also, in 
patient with LV dysfunction, CO may reach a plateau state 
at high exercise intensity, during which further increase in 
workload is not translated into an increase in CO (16).
In this study by van Riel et al., patients without TR or 
in whom TR signal was not recorded were excluded from 
the study. Although the reason for absent TR signal (apart 
from a competent tricuspid valve) is unknown, it is not 
unreasonable to postulate that it could be related to poor 
signal quality. Therefore, the real feasibility of using TR 
signal for PAP calculation could be lower than that reported, 
after taking into account the exclusion criterion alluded 
to earlier. Our group has previously shown that exercise 
SPAP is feasible and reproducible in high-volume Heart 
Valve Clinics with dedicated imaging protocols and skilled 
operators. In patients with secondary mitral regurgitation, 
we could achieve a feasibility rate of 94% using semi-supine 
bicycle ergometer for SPAP measurement, without the need 
for contrast administration (13).
This study also highlights the importance of obtaining 
high-quality Doppler echocardiographic signals. Indeed, in 
selected instances, the quality of Doppler echocardiographic 
signals can be improved by the administration of contrast 
or the use of dedicated imaging protocol. The use of 
agitated colloid enhancement has been shown to improve 
the detection of TR, which was not apparent or absent on 
non-contrasted study (12). Although there is an inherent 
risk of pressure overestimation from ‘spike’ noise artefact, 
it is by and large a useful tool and should be considered 
when the Doppler signal is of suboptimal quality. Both 
the exercise and imaging protocols should be standardised 
and optimised for exercise echocardiography, which calls 
for multiple imaging parameters within a limited amount 
of time (6). For the assessment of PHT as a consequence 
of valvular heart diseases, our group advocate semi-
supine bicycle ergometer, with the imaging table tilted 
according to optimal imaging windows. Symptom-limited 
graded exercise protocol, starting at 25 watts, followed 
by an increase of 25 watts every 2 min up to ≥80% of 
age-predicted target heart rate is recommended. The 
echocardiogram is performed continuously throughout 
exercise, allowing for PAP, ventricular sizes and functions 
assessment. Rather than interpreting elevated PAP in 
isolation, we recommend an integrated approach, taking 
into account patient’s age, exercise load, CO and systemic 
blood pressure for a comprehensive interpretation (6).
Despite its potential clinical utility and non-invasive 
nature, exercise PHT has yet to receive the recognition and 
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attention it deserves. Historically, exercise PHT was part of 
the hemodynamic definition of PHT since the 1st World 
Symposium of PHT back in 1973 in Geneva. It was not until 
the 4th World Symposium of PHT in 2008 in Dana Point that 
exercise PHT was removed from the definition of PHT due 
to the lack of clear distinction of normal physiological from 
pathological state during exercise (2). There was considerable 
overlap with that observed in normal healthy population, 
especially in athletes or those above 50 years of age (2). Another 
problem with the definition of exercise PHT is that PAP varies 
according to the level, type and posture of exercise and there 
is a lack of standardization on these parameters. To overcome 
these limitations, new definitions of exercise PHT has been 
proposed. In the work by Herve et al., the authors proposed a 
composite definition of exercise PHT, which included mean 
pulmonary pressure, MPAP >30 mmHg and total pulmonary 
resistance >3 mmHg/L/min (14). The sensitivity and 
specificity of this improved definition were high, at 0.98 and 
1.0 respectively. Instead of using PAP as the sole parameter, 
the effect of total pulmonary resistance, derived from MPAP/
CO, was taken into account. The MPAP/CO ratio describes 
the steepness of PAP increase per unit increase of CO 
during exercise. It assesses the pressure-flow relationship, 
which should be relatively stable if the adaptation of 
pulmonary circulation is adequate. This approach helps to 
distinguish PHT from increased MPAP due to increased 
flow in healthy subject with normal total pulmonary 
resistance and has been gaining grounds in recent years (15). 
Apart from the progress made in the optimal definition of 
exercise PHT, there has also been interest in the methods 
of pulmonary pressures measurement. It has been suggested 
that serial PHT measurement during graded exercise 
might be a better alternative to peak exercise SPAP in 
conditions such as pulmonary arterial hypertension and 
scleroderma (16). This approach, however, is technically 
challenging and its application in other conditions calls 
for clinician’s judgement and discretion. The Heart Valve 
Clinic International Database (HAVEC) group advocates 
peak exercise SPAP for patients with valvular heart disease, 
considering the need to accommodate multiple imaging 
parameters within a limited imaging window period (17).
The take home messages are two-fold. First, this study 
strengthens the role of non-invasive imaging modality such 
as Doppler echocardiography and highlights the importance 
of obtaining high quality TR signals for meaningful PAP 
calculation. Second, the MPAP to workload ratio was able 
to predict abnormal pulmonary vascular response during 
exercise with good sensitivity and specificity. This study 
comes after the 2015 European Society of Cardiology 
and the European Respiratory Society (ESC/ERS) PHT 
guidelines, which recommend the use of echocardiography 
to evaluate the probability of PHT and defer the 
measurement of PAP to right heart catheterisation (18). 
In this regard, echocardiography could be a useful first 
line screening tool for patients with suspected PHT and a 
gatekeeper for right heart catheterisation by risk stratifying 
patients into low, intermediate and high echocardiographic 
probability of PHT. In terms of clinical application, despite 
the good correlation with right heart catheterisation, 
Doppler echocardiography should not be regarded as an 
alternative to right heart catheterisation. Echocardiography 
nevertheless plays a complementary role in the monitoring 
of the hemodynamic consequences of PHT such as 
left and right atrial/ventricular overload or dysfunction 
(Figure 1). It is also the ideal modality for serial non-
invasive monitoring of pulmonary pressures. Depends on 
the goals of the managing physicians, echocardiography 
or right heart catheterisation can be considered under 
different circumstances. If the purpose is to confirm or 
refute the diagnosis of PHT with certainty and to further 
characterise the groups of PHT, it is probably prudent to 
proceed with right heart catheterisation. In patients with 
valvular diseases, e.g., symptomatic but non-severe mitral 
regurgitation or mitral stenosis, mild mitral regurgitation 
before cardiopulmonary bypass surgery, asymptomatic 
severe mitral regurgitation or mitral stenosis, as well as 
asymptomatic severe aortic stenosis, there is abundant 
evidence supporting the use of echocardiographic Doppler-
derived SPAP at determining the decision for surgery or 
follow-up frequency (6-10,17,19,20).
All in all, the work by van Riel et al. is commendable. It is 
a well thought-out and elegantly executed study that adds to 
the confidence of PHT diagnosis using echocardiography. 
It calls for further, larger studies, preferably in a wider 
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